Daiso is one of the world's largest manufacturers of spherical chromatographic-grade silica gel.
Company Description
Daiso is one of the world's largest manufacturers of spherical chromatographic-grade silica gel. The company's high-resolution chromatography products carrying the DAISOGEL brand name are designed for a broad range of applications. Many of the series of products are available in a range of particle and pore sizes and are offered in both analytical and preparative grades. The DAISOGEL products offer selectivities to achieve the separation of the many classes of chemicals encountered by the chromatographer engaged in research, industrial, or pharmaceutical analysis.
Chief Chromatographic Techniques Supported
Markets Served
With the U.S. focus on the demanding pharmaceutical market, Daiso's media must deliver consistent performance from analytical through prep to process in the development and commercialization of drug substances. For this purpose, a new Bio series media was introduced in 2006 to specifically address peptide and protein purification.
Major Products/Services
Facilities
Daiso is now a global business; it has 13 locations in Japan and 4 overseas in the U.S., Europe, and China. International sales are a fast-growing segment of Daiso's business. A new, high-rise building was opened in Osaka in 2006 to provide a larger head office for the growing business.
Daiso Co. Ltd.
1-12-18, Awaza, Nishi-ku, Osaka 550-0011, Japan
Daiso Fine Chem USA, Inc.,
275 Saratoga Avenue, Suite 102, Santa Clara, CA 95050
Daiso Fine Chem GmbH
Immermannstrasse 13, 40210, Duesseldorf, Germany
TELEPHONE
(408) 855-8789
Germany: +49-211-83025168
FAX
(408) 855-8784
Germany: +49-211-83025213
WEB SITE
NUMBER OF EMPLOYEES
Worldwide: 745
YEAR FOUNDED
1915
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.